PRKAA1 and type 2 diabetes mellitus: Our observations that eNOS Ser1177 phosphorylation is significantly reduced in cells from CAD patients with T2D implies that elevated AMPK activity alone against a background of T2D is not sufficient to increase eNOS phosphorylation at this residue.